2024-08-01 2025-07-31 false Capium Accounts Production 1.1 07304961 2024-08-01 2025-07-31 07304961 bus:FullAccounts 2024-08-01 2025-07-31 07304961 bus:FRS102 2024-08-01 2025-07-31 07304961 bus:AuditExemptWithAccountantsReport 2024-08-01 2025-07-31 07304961 bus:SmallCompaniesRegimeForAccounts 2024-08-01 2025-07-31 07304961 bus:PrivateLimitedCompanyLtd 2024-08-01 2025-07-31 07304961 2024-08-01 2025-07-31 07304961 2025-07-31 07304961 bus:RegisteredOffice 2024-08-01 2025-07-31 07304961 core:WithinOneYear 2025-07-31 07304961 core:AfterOneYear 2025-07-31 07304961 1 2024-08-01 2025-07-31 07304961 bus:Director1 2024-08-01 2025-07-31 07304961 bus:Director1 2025-07-31 07304961 bus:Director1 2023-08-01 2024-07-31 07304961 2023-08-01 07304961 bus:LeadAgentIfApplicable 2024-08-01 2025-07-31 07304961 2023-08-01 2024-07-31 07304961 2024-07-31 07304961 core:WithinOneYear 2024-07-31 07304961 core:AfterOneYear 2024-07-31 07304961 bus:EntityAccountantsOrAuditors 2023-08-01 2024-07-31 07304961 core:PlantMachinery 2024-08-01 2025-07-31 07304961 core:PlantMachinery 2025-07-31 07304961 core:PlantMachinery 2024-07-31 07304961 core:LeasedAssetsHeldAsLessee core:PlantMachinery 2025-07-31 07304961 core:LeasedAssetsHeldAsLessee core:PlantMachinery 2024-07-31 07304961 core:CostValuation core:Non-currentFinancialInstruments 2025-07-31 07304961 core:CostValuation core:Non-currentFinancialInstruments 2024-07-31 07304961 core:AdditionsToInvestments core:Non-currentFinancialInstruments 2025-07-31 07304961 core:DisposalsDecreaseInInvestments core:Non-currentFinancialInstruments 2025-07-31 07304961 core:RevaluationsIncreaseDecreaseInInvestments core:Non-currentFinancialInstruments 2025-07-31 07304961 core:Non-currentFinancialInstruments 2025-07-31 07304961 core:Non-currentFinancialInstruments 2024-07-31 07304961 core:ShareCapital 2025-07-31 07304961 core:ShareCapital 2024-07-31 07304961 core:RetainedEarningsAccumulatedLosses 2025-07-31 07304961 core:RetainedEarningsAccumulatedLosses 2024-07-31 07304961 dpl:Item1 2024-08-01 07304961 dpl:Item1 2025-07-31 07304961 dpl:Item1 2023-08-01 07304961 dpl:Item1 2024-07-31 iso4217:GBP xbrli:shares xbrli:pure

Registered Number: 07304961
England and Wales
DR CARE HEALTH LTD
Unaudited Financial Statements
Period of accounts Start date: 01 August 2024 End date: 31 July 2025

DR CARE HEALTH LTD Contents Page For the year ended 31 July 2025
Balance sheet | 1
Notes to the financial statements | 2

DR CARE HEALTH LTD Balance Sheet As at 31 July 2025
| Notes | 2025 £ |  | 2024 £
--- | --- | --- | --- | ---
Fixed assets |  |  |
Tangible fixed assets | 3 | 4,542 |  | 6,056
|  | 4,542 |  | 6,056
Current assets |  |  |
Cash at bank and in hand |  | 7,446 |  | 7,387
Creditors: amount falling due within one year | 4 | (11,590) |  | (14,020)
Net current assets |  | (4,144) |  | (6,633)
Total assets less current liabilities |  | 398 |  | (577)
Provisions for liabilities | 5 | (895) |  | (1,190)
Net assets |  | (497) |  | (1,767)
Capital and reserves |  |  |
Called up share capital |  | 100 |  | 100
Profit and loss account |  | (597) |  | (1,867)
Shareholders' funds |  | (497) |  | (1,767)
For the year ended 31 July 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. Director's responsibilities: The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476. The director acknowledges their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts. These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime. In accordance with Section 444 of the Companies Act 2006, the profit and loss account has not been delivered to the Registrar of Companies. The financial statements were approved by the director on 16 April 2026 and were signed by:
------------------------------- Suzhi Liu Director
1

DR CARE HEALTH LTD Notes to the Financial Statements For the year ended 31 July 2025
General Information DR CARE HEALTH LTD is a private company, limited by shares, registered in England and Wales, registration number 07304961, registration address 18 JERDAN PLACE, LONDON , SW6 1BH. The presentation currency is £ sterling.
1. | Accounting policies Significant accounting policies Statement of compliance These financial statements have been prepared in compliance with FRS 102 – The Financial Reporting Standard applicable in the UK and Republic of Ireland and the Companies Act 2006. Basis of preparation The financial statements have been prepared under the historical cost convention as modified by the revaluation of land and buildings and certain financial instruments measured at fair value in accordance with the accounting policies. The financial statements are prepared in sterling which is the functional currency of the company. Going concern basis The directors believe that the company is experiencing good levels of sales growth and profitability, and that it is well placed to manage its business risks successfully. Accordingly, they have a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. Thus they continue to adopt the going concern basis of accounting in preparing the financial statements. Turnover Turnover comprises the invoiced value of goods and services supplied by the company, net of Value Added Tax and trade discounts. Taxation Taxation represents the sum of tax currently payable and deferred tax. Tax is recognised in the statement of income, except to the extent that it relates to items recognised in other comprehensive income or directly in capital and reserves. The company’s liability for current tax is calculated using the tax rates and laws that have been enacted or substantively enacted at the reporting date. Current and deferred tax assets and liabilities are not discounted Deferred taxation Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the reporting date. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the reporting date that are expected to apply to the reversal of the timing difference. Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Current and deferred tax assets and liabilities are not discounted. Tangible fixed assets Tangible fixed assets, other than freehold land, are stated at cost or valuation less depreciation and any provision for impairment. Depreciation is provided at rates calculated to write off the cost or valuation of fixed assets, less their estimated residual value, over their expected useful lives on the following basis:
Plant and Machinery | 25% Reducing Balance
Provisions Provisions are recognised when the company has a present obligation as a result of a past event which it is more probable than not will result in an outflow of economic benefits that can be reasonably estimated. Financial instruments The company has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments. Financial instruments are recognised in the company's balance sheet when the company becomes party to the contractual provisions of the instrument. Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.
2. | Average number of employees Average number of employees during the year was 3 (2024 : 3).
3. | Tangible fixed assets
Cost or valuation | Plant and Machinery |  | Total
| £ |  | £
At 01 August 2024 | 21,940 |  | 21,940
Additions | - |  | -
Disposals | - |  | -
At 31 July 2025 | 21,940 |  | 21,940
Depreciation
At 01 August 2024 | 15,884 |  | 15,884
Charge for year | 1,514 |  | 1,514
On disposals | - |  | -
At 31 July 2025 | 17,398 |  | 17,398
Net book values
Closing balance as at 31 July 2025 | 4,542 |  | 4,542
Opening balance as at 01 August 2024 | 6,056 |  | 6,056
4. | Creditors: amount falling due within one year
| 2025 £ |  | 2024 £
--- | --- | --- | ---
Corporation Tax | 556 |  | 0
PAYE & Social Security | 88 |  | 74
Other Creditors | 1 |  | 1
Director: Suzhi Liu | 10,945 |  | 13,945
| 11,590 |  | 14,020
5. | Provisions for liabilities
| 2025 £ |  | 2024 £
--- | --- | --- | ---
Deferred Tax | 863 |  | 1,151
Pension Provisions | 32 |  | 39
| 895 |  | 1,190
2